Desire, from my understanding the talks with commercialisation partners are ongoing and the company is working with a consultant with the licensing negotiations, these are aimed at being finalised before the end of year so we may have a little way to go. Commercial scale production is now complete and what we as holders want to continue seeing is good trial results.
Overtures, well in, I will be lurking around and topping up on any weakness, still some time up our sleeves I reckon and will capitalise on the impatience of others:))
- Forums
- ASX - By Stock
- TIS
- interesting
interesting, page-19
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online